Canadian Myeloma Research Group

This study is testing a combination of four drugs to control multiple myeloma in older adults who are not eligible for a stem cell transplant. The treatment plan is flexible—a fourth drug is added only if a patient's initial response isn't deep enough. The goal is to see how well…